TABLE 1

Clinical characteristics, PCA ratio, QTc, and STD measurements in participants according to survival status

SurvivorsAll-cause deathPSurvivors and non-CVD deathCVD deathP
n83915593856
Age (years)56 ± 860 ± 9<0.00157 ± 861 ± 9<0.001
Sex (% female)62.956.10.13162.650.00.082
BMI (kg/m2)32.4 ± 6.130.1 ± 6.2<0.00132.2 ± 6.230.7 ± 5.40.154
Diastolic blood pressure (mmHg)78 ± 1076 ± 120.00978 ± 1079 ± 110.953
Systolic blood pressure (mmHg)131 ± 19133 ± 250.153131 ± 19137 ± 270.035
Fasting glucose (mmol/l)11.5 ± 4.511.7 ± 5.10.07011.5 ± 4.612.0 ± 4.40.012
GHb (%)8.76 ± 2.518.35 ± 2.430.2358.73 ± 2.529.12 ± 1.760.776
HDL cholesterol (mmol/l)1.09 ± 0.281.11 ± 0.340.9921.09 ± 0.280.93 ± 0.210.002
LDL cholesterol (mmol/l)2.90 ± 0.802.82 ± 1.140.5202.87 ± 0.833.23 ± 1.290.004
Triglycerides (mg/dl)178 ± 165187 ± 1930.668177 ± 162219 ± 2630.033
Albuminuria (log mg/g)3.73 ± 2.155.00 ± 2.44<0.0013.84 ± 2.215.03 ± 2.48<0.001
Prevalent CHD (%)<0.0010.004
 None77.758.175.757.1
 Possible19.031.620.332.1
 Definite3.310.34.110.7
Smoking (%)0.8320.600
 Never32.534.833.326.8
 Previous40.937.440.439.3
 Current26.627.726.333.9
STD (μV)−14.4 ± 19.6−25.3 ± 28.2<0.001−15.1 ± 20.5−31.3 ± 30.7<0.001
QTc (ms)435 ± 24444 ± 30<0.001436 ± 25442 ± 320.028
PCA ratio (%)18.7 ± 12.222.5 ± 14.8<0.00119.0 ± 12.524.2 ± 15.20.001
  • Data are means ± SD unless otherwise indicated. CVD, cardiovascular disease.